Inhaled Nitric Oxide Sales Market will reach 1490 million US$ by the end of 2025

This report studies the global Inhaled Nitric Oxide market status and forecast, categorizes the global Inhaled Nitric Oxide market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

Ask for Discount on Research Report@ https://www.qyresearch.com/request-discount/form/235564/global-inhaled-nitric-oxide-sales-market

The market is highly concentrated, with high technical and professional level. Key vendors in this market are Mallinckrodt, Praxair and Air Liquide, they are taking up to 91.19% market share in 2017. Inhaled Nitric Oxide types commonly used in this market are 800 ppm and 100 ppm, small players tend to produce lower purity products, such as 1000 ppm or so.

According to the research, North America and Europe comprised the biggest consumption areas. Other markets like Japan and China are growing relatively slow.

Though the gross margin is high, but with complex production process and acquisition between enterprises, we tend to believe that this market is going to keep the monopoly status in the forecast period.

The global Inhaled Nitric Oxide market is valued at 780 million US$ in 2017 and will reach 1490 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2018-2025.

Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/235564/global-inhaled-nitric-oxide-sales-market

The major players covered in this report

    Mallinckrodt

    Praxair

    Air Liquide

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

    United States

    Europe

    China

    Japan

    Southeast Asia

    India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

    99.92% Purity

    99.99% Purity

    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

    ARDS

    PPHN

    Other Diseases